Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

Overview of attention for article published in Arthritis Research & Therapy, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 1 news story.

Action Points Note that this meta-analysis demonstrated that a switch from ineffective DMARD therapy to tocilizumab was…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.